Trehalolipid biosurfactants from nonpathogenic Rhodococcus actinobacteria with diverse immunomodulatory activities

New Biotechnology

Volumn 32, Issue 6, 2015, Pages 559-568

  Kuyukina, Maria S ^a,b   Ivshina, Irena B ^a,b   Baeva, Tatiana A ^a   Kochina, Olesia A ^a   Gein, Sergey V ^a,b   Chereshnev, Valery A ^a,b,c  

^a INSTITUTE OF ECOLOGY AND GENETICS OF MICROORGANISMS   (Russian Federation)

^b PERM STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF IMMUNOLOGY AND PHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES;

ACTINOBACTERIA; BIO-SURFACTANTS; BIOCHEMICAL PROPERTIES; IMMUNOLOGICAL ACTIVITY; IMMUNOMODULATORY ACTIVITIES; LOW TOXICITY; MOLECULAR MECHANISM; MYCOBACTERIUM TUBERCULOSIS;

SURFACE ACTIVE AGENTS;

ACYL COENZYME A; ANTINEOPLASTIC AGENT; ARABINOGALACTAN; BIOSURFACTANT; CD1 ANTIGEN; CD18 ANTIGEN; CORD FACTOR; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MYCOLIC ACID; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDOGLYCAN; RHAMNOLIPID; SUPEROXIDE; TOLL LIKE RECEPTOR 4; TREHALOLIPID; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; IMMUNOLOGIC FACTOR; LIPID; SURFACTANT;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BIOMEDICINE; BIOSAFETY; CELL INTERACTION; DENDRITIC CELL; GRANULOMA; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; MOLECULAR MECHANICS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHODOCOCCUS; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CLASSIFICATION; IMMUNOLOGY; METABOLISM; MOUSE; SPECIES DIFFERENCE;

ANIMALS; IMMUNOLOGIC FACTORS; LIPIDS; MICE; RHODOCOCCUS; SPECIES SPECIFICITY; SURFACE-ACTIVE AGENTS;

EID: 84940960111     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2015.03.006     Document Type: Review

References (82)

1. Neu T.R. Significance of bacterial surface-active compounds in interaction of bacteria with interfaces. Microbiol Rev 1996, 60:151-166.
2. Ron E.Z., Rosenberg E. Natural roles of biosurfactants. Environ Microbiol 2001, 3:229-236.
3. Cameotra S.S., Makkar R.S. Recent applications of biosurfactants as biological and immunological molecules. Curr Opin Microbiol 2004, 7:262-266.
4. Franzetti A., Gandolfi I., Bestetti G., Smyth T.J.P., Banat I.M. Production and applications of trehalose lipid biosurfactants. Eur J Lipid Sci Technol 2010, 112:617-627.
5. Marchant R., Banat I.M. Microbial biosurfactants: challenges and opportunities for future exploitation. Trends Biotechnol 2012, 30:558-565.
6. Transparency Market Research Report Microbial Biosurfactants Market (Rhamnolipids, Sophorolipids, Mannosylerythritol Lipids (MEL) and Other) for Household Detergents, Industrial & Institutional Cleaners, Personal Care, Oilfield Chemicals, Agricultural Chemicals, Food Processing, Textile and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014-2020; 2014. 74 pp.
7. Makkar R.S., Cameotra S.S., Banat I.M. Advances in utilization of renewable substrates for biosurfactant production. AMB Express 2011, 1:5. http://www.amb-express.com/content/1/1/5.
8. Henkel M., Müller M.M., Kügler J.H., Lovaglio R.B., Contiero J., Syldatk C., et al. Rhamnolipids as biosurfactants from renewable resources: concepts for next-generation rhamnolipid production. Process Biochem 2012, 47:1207-1219.
9. Kitamoto D., Isoda H., Nakahara T. Functions and potential applications of glycolipid biosurfactants - from energy-saving materials to gene delivery carriers. J Biosci Bioeng 2002, 94:187-201.
10. Lang S. Biological amphiphiles microbial biosurfactants. Curr Opin Colloid Interface Sci 2002, 7:12-20.
11. Gudiña E.J., Rangarajan V., Sen R., Rodrigues L.R. Potential therapeutic applications of biosurfactants. Trends Pharm Sci 2013, 34:667-675.
12. Lang S., Philp J.C. Surface-active lipids in rhodococci. Antonie van Leeuwenhoek Int J Gen Mol Microbiol 1998, 74:59-70.
13. Asselineau J., Lanéelle G. Mycobacterial lipids: a historical perspective. Front Biosci 1998, 3:164-174.
14. Noll H., Bloch H., Asselineau J., Lederer E. The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim Biophys Acta 1956, 20:299-309.
15. Margaritis A., Zajic J.E., Gerson D.F. Production and surface-active properties of microbial surfactants. Biotechnol Bioeng 1979, 21:1151-1162.
16. Cooper D.G., Zajic J.E. Surface-active compounds from microorganisms. Appl Microbiol 1980, 26:229-252.
17. Retzinger G.S., Meredith S.C., Takayama K., Hunter R.L., Kezdy F.J. The role of surface in the biological activities of trehalose 6,6-dimicolate. J Biol Chem 1981, 256:8208-8216.
18. Shimakata T., Minatogawa Y. Essential role of trehalose in the synthesis and subsequent metabolism of corynomycolic acid in Corynebacterium matruchotii. Arch Biochem Biophys 2000, 380:331-338.
19. Puech V., Chami M., Lemassu A., Lanéelle M.-A., Schiffler B., Gounon P., et al. Structure of the cell envelope of Corynebacteria: importance of the non-covalently bound lipids in the formation of the cell wall permeability barrier and fracture plane. Microbiology 2001, 147:1365-1382.
20. Fujita Y., Naka T., McNeil M., Yano I. Intact molecular characterization of cord factor (trehalose 6,6'-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 2005, 151:3403-3416.
21. Fujiwara N., Pan J., Enomoto K., Terano Y., Honda T., Yano I. Production and partial characterization of anti-cord factor (trehalose-6,6P-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclasses of Mycobacterium tuberculosis or Mycobacterium avium. FEMS Immunol Med Microbiol 1999, 24:141-149.
22. Ryll R., Kumazawa Y., Yano I. Immunological properties of trehalose dimycolate cord factor and other mycolic acid-containing glycolipids - a review. Microbiol Immunol 2001, 45:801-811.
23. Summermatter K., Binz T. Biosafety-Europe: recommendations for the harmonisation of biosafety and laboratory biosecurity practices in Europe on the basis of a comparative approach. EuroReference 2012, 07:45-47.
24. Kuyukina M.S., Ivshina I.B. Rhodococcus biosurfactants: biosynthesis, properties, and potential applications. Biology of Rhodococcus 2010, 292-313. Springer-Verlag, Berlin. H.M. Alvarez (Ed.).
25. Munstermann B., Poremba K., Lang S., Wagner F. Studies on environmental compatibility: influence of (bio)surfactants on marine microbial and enzymatic systems. Proceedings of international symposium soil decontamination using biological processes 1992, 414-420.
26. Ivshina I.B., Kuyukina M.S., Plilp J.C., Christofi N. Oil desorption from mineral and organic materials using biosurfactant complexes produced by Rhodococcus species. World J Microbiol Biotechnol 1998, 14:711-717.
27. Kuyukina M.S., Ivshina I.B., Gein S.V., Baeva T.A., Chereshnev V.A. In vitro immunomodulating activity of biosurfactant glycolipid complex from Rhodococcus ruber. Bull Exp Biol Med 2007, 144:326-330.
28. Gein S.V., Kuyukina M.S., Ivshina I.B., Baeva T.A., Chereshnev V.A. In vitro cytokine stimulation assay for glycolipid biosurfactant from Rhodococcus ruber: role of monocyte adhesion. Cytotechnology 2011, 63:559-566.
29. Marqués A.M., Pinazo Farfan A.M., Aranda F.J., Teruel J.A., Ortiz A., Manresa A., et al. The physicochemical properties and chemical composition of trehalose lipids produced by Rhodococcus erythropolis 51T7. Chem Phys Lipids 2009, 158:110-117.
30. Isoda H., Shinmoto H., Matsumura M., Nakahara T. Succinoyl trehalose lipid induced differentiation of human monocytoid leukemic cell line U937 into monocyte-macrophages. Cytotechnology 1996, 19:79-88.
31. Sakaguchi I., Ikeda N., Nakayama N., Kato Y., Yano I., Kaneda K. Trehalose 6,6-dimycolate cord factor neovascularization trough vascular endothelial growth factor production by neutrophiles and macrophages. Infect Immunity 2000, 68:2043-2052.
32. Ueda S., Fujiwara N., Naka T., Sakaguchi I., Ozeki Y., Yano I., et al. Structure-activity relationship of mycoloyl glycolipids derived from Rhodococcus sp. 4306. Microb Pathog 2001, 30:91-99.
33. Gotoh K., Mitsuyama M., Imaizumi S., Kawamura I., Yano I. Mycolic acid-containing glycolipid as a possible virulence factor of Rhodococcus equi for mice. Microbiol Immunol 1991, 35:175-185.
34. Moody D.B., Guy M.R., Grant E., Cheng T.Y., Brenner M.B., Besra G.S., et al. Cdlb-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 2000, 192:965-976.
35. Kaneda K., Sumi Y., Kurano F., Kato Y., Yano I. Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra. Infect Immun 1986, 54:869-875.
36. Matsunaga I., Oka S., Inoue T., Yano I. Mycoloyl glycolipids stimulate macrophages to release a chemotactic factor. FEMS Microbiol Lett 1990, 67:49-54.
37. Natsuhara Y., Oka S., Kaneda K., Yano I. Parallel antitumor, granuloma forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. Cancer Immunol Immunother 1990, 31:99-106.
38. de Boer E.C., de Reijke T.M., Vos P.C.N., Kurth K.-H., Schamhart D.H.J. Immunostimulation in the urinary bladder by local application of Nocardia rubra cell-wall skeletons (Rubratin) and bacillus Calmette-Guérin as therapy for superficial bladder cancer: a comparative study. Clin Infect Dis 2000, 31:S109-S114.
39. Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A., et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of Toll-like receptors. Infect Immun 2000, 68:6883-6890.
40. Chereshnev V.A., Gein S.V., Baeva T.A., Galkina T.V., Kuyukina M.S., Ivshina I.B. Modulation of cytokine secretion and oxidative metabolism of innate immune effectors by Rhodococcus biosurfactant. Bull Exp Biol Med 2010, 149:734-738.
41. Baeva T.A., Gein S.V., Kuyukina M.S., Ivshina I.B., Kochina O.A., Chereshnev V.A. Effect of glycolipid Rhodococcus biosurfactant on secretory activity of neutrophils in vitro. Bull Exp Biol Med 2014, 157:238-242.
42. Ito T., Connett J.M., Kunkel S.L., Matsukawa A. The linkage of innate and adaptive immune response during granulomatous development. Front Immunol 2013, 4:10.
43. Borders C.W., Courtney A., Ronen K., Laborde-Lahoz M.P., Guidry T.V., Hwang S.-A., et al. Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate. Scand J Immunol 2005, 62:123-130.
44. Yasuda K. Complement activation by mycoloyl glycolipids from Mycobacterium tuberculosis and Rhodococcus ruber. Osaka City Med J 1999, 45:159-174.
45. 3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate in mice. Microbiology 2006, 152:3765-3775.
46. Behling C.A., Perez R.L., Kidd M.R., Staton G.W., Hunter R.L. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann Clin Lab Sci 1993, 23:256-266.
47. Fujita T., Sugimoto N., Yokoi F., Ohtsubo Y., Ikutoh M., Kato Y., et al. Induction of interferons (IFNs) and tumor necrosis factor (TNF) in mice by a novel glycolipid trehalose 2,3,6'-trimycolate from Rhodococcus aurantiacus (Gordona aurantiaca). Microbiol Immunol 1990, 34:523-532.
48. Matsunaga I., Oka S., Fujiwara N., Yano I. Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycoloyl glycolipids from Rhodococcus ruber (Nocardia rubra). J Biochem 1996, 120:663-670.
49. Harris S.P., Fujiwara N., Mealey R.H., Alperin D.C., Naka T., Goda R. Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes. Microbiology 2010, 156:1836-1847.
50. Barot-Ciorbaru R. Immunomodulation by bacterial fractions. Int J Immunopharmacol 1994, 16:469-473.
51. Leibovici J., Hoenig S., Pinchassov A., Barot-Ciorbaru R. Antitumoral activity of an immunomodulatory fraction of Nocardia opaca: mechanism of action. Int J Immunopharmacol 1994, 16:475-480.
52. Barot-Ciorbaru R., Linna T.J., Patel M.R., Altman J., Carnaud C. Enhancement of natural killer cell activity by Nocardia opaca fractions. Scand J Immunol 1989, 29:133-141.
53. Liang X.-J., Chen C., Zhao Y., Wang P.C. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol 2010, 596:467-488.
54. Isoda H., Kitamoto D., Shinmoto H., Matsumura M., Nakahara T. Microbial extracellular glycolipid induction of differentiation and inhibition of the protein kinase C activity of human promyelocytic leukemia cell line HL-60. Biosci Biotechnol Biochem 1997, 61:609-614.
55. Sudo T., Zhao X., Wakamatsu Y., Shibahara M., Nomura N., Nakahara T., et al. Induction of the differentiation of human HL-60 promyelocytic leukemia cell line by succinoyl trehalose lipids. Cytotechnology 2000, 33:259-264.
56. Koivunen J., Aaltonen V., Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Lett 2006, 235:1-10.
57. Groves E., Dart A.E., Covarelli V., Caron E. Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci 2008, 65:1957-1976.
58. Costa C., Incio J., Soares R. Angiogenesis and chronic inflammation: cause or consequence?. Angiogenesis 2007, 10:149-166.
59. Indrigo J., Hunter R.L., Actor J.K. Influence of trehalose 6,6H-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 2002, 148:1991-1998.
60. Bowdish D.M., Sakamoto K., Kim M.J., Kroos M., Mukhopadhyay S., Leifer C.A., et al. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 2009, 5:e1000474.
61. Kingeter L.M., Lin X. C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses. Cell Mol Immunol 2012, 9:105-112.
62. Werninghaus K., Babiak A., Gross O., Htslscher C., Dietrich H., Agger E.M., et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation. J Exp Med 2009, 206:89-97.
63. Ishikawa E., Ishikawa T., Morita Y.S., Toyonaga K., Yamada H., Takeuchi O., et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 2009, 206:2879-2888.
64. Yamasaki S., Ishikawa E., Sakuma M., Hara H., Ogata K., Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 2008, 9:1179-1188.
65. Lee W., Kang J.-S., Yan J.-J., Lee M.S., Jeon B.Y., Cho S.N., et al. Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the Mincle pathway. PLoS Pathog 2012, 8:1-18.
66. Furukawa A., Kamishikiryo J., Mori D., Toyonaga K., Okabe Y., Storey J.R., et al. Structural analysis for glycolipid recognition by the C-type lectins Mincle and MCL. Proc Natl Acad Sci U S A 2013, 110:17438-17443.
67. Schoenen H., Bodendorfer B., Hitchens K., Manzanero S., Werninghaus K., Nimmerjahn F., et al. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 2010, 184:2756-2760.
68. Jégouzo S.A.F., Harding E.C., Acton O., Rex M.J., Fadden A.J., Taylor M.E., et al. Defining the conformation of human Mincle that interacts with mycobacterial trehalose dimycolate. Glycobiology 2014, 24:1291-1300.
69. Toyonaga K., Miyake Y., Yamasaki S. Characterization of the receptors for mycobacterial cord factor in guinea pig. PLOS ONE 2014, 9.
70. Yamasaki S., Ishikawa E., Sakuma M., Hara H., Ogata K., Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 2008, 9:1179-1188.
71. Kawata K., Illarionov P., Yang G.X., Kenny T.P., Zhang W., Tsuda M., et al. Mincle and human B cell function. J Autoimmun 2012, 39:315-322.
72. Vijayan D., Radford K.J., Beckhouse A.G., Ashman R.B., Wells C.A. Mincle polarizes human monocyte and neutrophil responses to Candida albicans. Immunol Cell Biol 2012, 90:889-895.
73. Flornes L.M., Bryceson Y.T., Spurkland A., Lorentzen J.C., Dissen E., Fossum S. Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics 2004, 56:506-517.
74. Cheng J., Khan A., Timmer M., Stocker B. Endogenous and exogenous CD1-binding glycolipids. Int J Carbohydr Chem 2011, 201:1. 10.1155/2011/749591.
75. Khan A., Cheng J., Stocker B., Timmer M. Glycolipids and CD1: the crossroad between chemistry and immunology. Chem N Z 2010, 57-62.
76. Dascher C., Hiromatsu K., Naylor J., Brauer P., Brown K., Storey J.R., et al. Conservation of a CD1 multigene family in the guinea pig. J Immunol 1999, 163:5478-5488.
77. Hiromatsu K., Dascher C., Sugita M., Gingrich-Baker C., Behar S., Leclair K.P., et al. Characterization of guinea-pig group 1 CD1 proteins. Immunology 2002, 106:159-172.
78. Pirog T.P., Shevchuk T.A., Voloshina I.N., Karpenko E.V. Production of surfactants by Rhodococcus erythropolis strain EK-1, grown on hydrophilic and hydrophobic substrates. Appl Biochem Microbiol 2004, 40:470-475.
79. Cortes M.A.L.R.M., de Carvalho C.C.C.R. Effect of carbon sources on lipid accumulation in Rhodococcus cells. Biochem Eng J 2015, 94:100-105.
80. Ciapina E.M.P., Melo W.C., Santa Anna L.M.M., Santos A.S., Freire G.M.G., Pereira N. Biosurfactant production by Rhodococcus erythropolis grown on glycerol. Appl Biochem Biotechnol 2006, 131:880-886.
81. Inaba T., Tokumoto Y., Miyazaki Y., Inoue N., Maseda H., Nakajima-Kambe T., et al. Analysis of genes for succinoyl trehalose lipid production and increasing production in Rhodococcus sp. strain SD-74. Appl Environ Microbiol 2013, 79:7082-7090.
82. Dogan I., Pagilla K.R., Webster D.A., Stark B.C. Expression of Vitreoscilla haemoglobin in Gordonia amarae enhances biosurfactant production. J Ind Microbiol Biotechnol 2006, 33:693-700.